Thermo Fisher Scientific Inc (NYSE:TMO) under-valued by 11%
Website | https://www.thermofisher.com/ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Fiscal Year End | Dec 31, 2020 |
Market Cap | $179,582,353,408 |
Beta | 0.759893 |
Average Volume | $1,761,442 |
Last Dividend | 0.92% |
Price on May 7, 2021 | $456.92 |
Autochartist™ Valuation | $507.59 |
Conclusion |
11% under-valued |
Download Report |